Inactive Instrument

Calendar Catalyst Biosciences Inc Nasdaq

Equities

US14888D1090

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI
2023	Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	CI

Chart calendar Catalyst Biosciences Inc

e6a35080a2e0786cedddf5778035fbea.n0kf6TSBQ7XYqMSfSPleQQT3B1Vr3zCYmEqQm7PfjTM.0wVMs3DZcsOom77JLI8HBkuHfT8_vWbU-Xmp2tS16VzFJiydXNgU7L3klQ~8dc8339bdb460cd8824cb4bbec393805

Upcoming events on Catalyst Biosciences Inc

No events available

Past events on Catalyst Biosciences Inc

08/03/2023	Q4 2022 Earnings Release (Projected)
12/01/2023	Ex-dividend day
27/12/2022 13:00	Catalyst Biosciences Inc and GNI Group Ltd Merger Call
20/09/2022	Ex-dividend day
15/08/2022 21:05	Interim 2022 Earnings Release
15/08/2022 16:00	Annual General Meeting
09/05/2022 13:30	Q1 2022 Earnings Release
31/03/2022 13:00	FY 2021 Earnings Release
04/01/2022	LifeSci Partners Corporate Access Event
18/11/2021 18:54	Piper Sandler Virtual Healthcare Conference
12/11/2021 13:30	Q3 2021 Earnings Call
12/11/2021 12:00	Q3 2021 Earnings Release
27/10/2021	American Society for Biochemistry and Molecular Biology Meeting
25/10/2021	Complement based Drug Development Summit
29/09/2021 15:00	Cantor Fitzgerald Global Healthcare Conference
15/09/2021 18:00	Investor Meeting - Fireside Chat
05/08/2021 13:00	Interim 2021 Earnings Release
19/07/2021 17:00	R&D Day
18/07/2021	International Society on Thrombosis and Haemostatis Virtual Congress - Subcutaneous Marzeptacog Alfa
18/07/2021	International Society on Thrombosis and Haemostatis Virtual Congress - Dose Selection of Marzeptacog

Annual results

Fiscal Period	December	2018	2019	2020	2021	2022
Net sales Million USD	Released Forecast Spread	0,01 0,30 -98%	0,00 0,00 -	20,9 19,0 10.25%	7,34 5,15 42.54%	0,79 0,79 0%
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-33,8 -32,8 -3.12%	-57,3 -58,1 1.42%	-57,4 -58,9 2.6%	-87,9 -89,0 1.26%	-30,4 -29,7 -2.33%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00 0,00 -	-55,2 -55,6 0.76%	-56,2 -57,9 2.87%	-87,9 -89,0 1.25%	-7,89 28,2 -128%
Net income Million USD	Released Forecast Spread	-30,1 -29,8 -0.86%	-55,2 -56,3 1.99%	-56,2 -57,9 2.87%	-87,9 -89,0 1.25%	-8,24 28,2 -129.23%
EPS USD	Released Forecast Spread	-40,2 -39,9 -0.75%	-69,0 -68,0 -1.47%	-43,9 -40,0 -9.88%	-43,0 -42,8 -0.47%	-3,90 13,5 -128.89%
Announcement Date		07/03/19	20/02/20	04/03/21	31/03/22	30/03/23

Quarterly results

Fiscal Period	December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3
Net sales Million USD	Released Forecast Spread	2,30 0,50 359.8%	2,44 0,25 876%	0,79 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.25%	-14,7 -15,6 5.96%	-5,72 -6,91 17.25%	-5,17 -3,25 -58.86%	-4,83 -4,13 -16.74%	0,18 -2,68 106.65%	-2,54 -2,54 0.04%	-1,62 -2,08 22.05%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.19%	-14,5 -15,1 3.65%	51,6 -6,82 857.18%	-4,88 -3,06 -59.4%	-40,1 -4,02 -898.41%	0,27 -2,51 110.9%	-2,47 -2,48 0.52%	-1,58 -2,03 22.36%
Net income Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.19%	-14,5 -15,1 3.65%	51,6 -6,82 857.18%	-4,88 -3,06 -59.4%	-40,5	0,26 -2,51 110.34%	-2,47 -2,48 0.44%	-1,58 -2,03 22.36%
EPS USD	Released Forecast Spread	-12,0 -9,95 -20.6%	-9,75 -9,55 -2.09%	-6,90 -6,60 -4.55%	24,6 -3,30 845.45%	-2,40 -1,50 -60%	-19,2	0,15 -1,05 114.29%	-1,05 -1,05 0%	-0,60 -0,75 20%
Announcement Date		12/11/21	31/03/22	09/05/22	15/08/22	14/11/22	30/03/23	15/05/23	14/08/23	26/10/23

Upcoming sector events for Catalyst Biosciences Inc

More events